NCT07620145

Brief Summary

Total knee arthroplasty (TKA) remains the only treatment for end-stage knee osteoarthritis, whereby the diseased ends of the bones comprising the knee joint are removed and replaced with prosthetic joint components. Approximately 500,000 of these procedures are performed annually in the United States. Despite an otherwise successful procedure and post-operative rehabilitation process, about 5% of all individuals will develop a flexion contracture after TKA. Flexion contracture limits the knee joint range of motion, which has negative impacts on activities of daily living and health-related quality of life. Standard of care treatment for resolving flexion contracture requires more surgery or, at minimum, more exposure to anesthesia to manipulate the joint and improve range of motion. The investigators have developed a non-invasive means for resolving flexion contracture, The investigators propose fixing a wedge to the sole of the patient's shoe such that the taller end of the wedge is located near the toes and the shorter end is closer to the heel. Biomechanically, this forces the individual to make ground contact during walking closer to the heel rather than the toes (which is typically observed in patients with flexion contracture). By forcing ground contact closer to the heel, patients gradually force their knee to extend (straighten) over time and resolve the flexion contracture. The aim of this pilot investigation is to test the hypothesis that the anterior wedge worn on the shoe during all walking activities for 4 weeks will reduce the severity of the flexion contracture in patients after TKA.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for early_phase_1

Timeline
Completed

Started Mar 2023

Typical duration for early_phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 16, 2023

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

December 19, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
5 months until next milestone

First Posted

Study publicly available on registry

June 2, 2026

Completed
Last Updated

June 2, 2026

Status Verified

May 1, 2026

Enrollment Period

2.8 years

First QC Date

December 19, 2024

Last Update Submit

May 26, 2026

Conditions

Keywords

walkingkneerange of motion

Outcome Measures

Primary Outcomes (1)

  • Gait biomechanics

    Participants will walk over level ground at a self-selected pace and one equivalent to average older adult walking speed.

    From enrollment to the end of treatment at 4 weeks

Secondary Outcomes (4)

  • Patient-reported outcomes

    From baseline to the end of the intervention at 4 weeks

  • Patient-reported outcomes

    From baseline to the end of the intervention at 4 weeks

  • Patient-reported outcomes

    From baseline to the end of the intervention at 4 weeks

  • Patient-reported outcomes

    From baseline to the end of the intervention at 4 weeks

Study Arms (1)

Orthotic

EXPERIMENTAL

Participants enrolled in this arm wear an anterior heel wedge, in the form of a shoe orthotic, to improve walking and reduce knee flexion contracture. The wedge is worn continuously on the shoe for 1 month.

Device: Anterior heel wedge

Interventions

A continuously-worn shoe anterior heel wedge that fits on the under surface of the shoe just under the toe box. When worn during walking, the anterior heel wedge may help to increase knee joint range of motion and reduce knee flexion contracture in patients after total knee arthroplasty.

Orthotic

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • over the age of 18 years
  • underwent primary, unilateral TKA and approved for participation by surgeon
  • present with flexion contracture in the operative limb (5 degrees or greater at least 3 months after surgery)
  • body mass index \<40kg/m\^2

You may not qualify if:

  • underwent revision TKA
  • underwent bilateral TKA
  • require use of assistive device to walk
  • inability to consistently comprehend and repeat back directions, including for reasons of not understanding/speaking English
  • current smoker

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UNC Charlotte

Charlotte, North Carolina, 28269, United States

Location

Related Publications (1)

  • Sappey-Marinier E, Fernandez A, Shatrov J, Batailler C, Servien E, Huten D, Lustig S. Management of fixed flexion contracture in primary total knee arthroplasty: recent systematic review. SICOT J. 2024;10:11. doi: 10.1051/sicotj/2024007. Epub 2024 Mar 26.

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 19, 2024

First Posted

June 2, 2026

Study Start

March 16, 2023

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

June 2, 2026

Record last verified: 2026-05

Locations